Press Release - Company Data

Lannett Expects Fiscal 2014 Financial Results to Far Exceed Prior Year
Posted 2014-08-18 00:13AMEX_LCI
today announced that it expects to report fiscal 2014 fourth quarter net sales of approximately $81 million and diluted earnings per share attributable to Lannett Company in the range of $0.60 and $0.

Lannett Signs Agreement to Be Exclusive U.S. Distributor of Authorized Generic of Hypertension Drug, ACEON®
Posted 2014-07-18 00:06NAI Editing
today announced that it has signed an agreement with Symplmed, Inc.

Lannett Announces Multi-Services Agreement with Sunshine Lake LLC, a U.S. Subsidiary of HEC Pharm Group
Posted 2014-05-12 00:01NAI Editing
today announced that it has entered into distribution and contract manufacturing services agreements with Sunshine Lake LLC, the U.S.

Lannett Receives FDA Approval for Diazepam Oral Solution (Concentrate), 5 mg/mL
Posted 2014-04-14 23:40NAI Editing
today announced that it has received approval from the U.S.

Lannett Establishes $50 Million Revolving Credit Facility
Posted 2013-12-18 23:30NAI Editing
today announced that it has established a new, five-year $50 million revolving credit facility with a syndicate of two lenders, Citibank, N.A., as administrative agent, and PNC Bank, National Associat

Lannett to Begin Trading on the New York Stock Exchange
Posted 2013-12-02 00:03NAI Editing
today announced that it will transfer the listing of its common stock to the New York Stock Exchange (NYSE) from NYSE MKT.

Lannett Announces Preliminary Fiscal 2014 First Quarter
Posted 2013-10-30 23:45NAI Editing
today announced that it expects to report fiscal 2014 first quarter net sales of approximately $45 million and adjusted earnings per share between $0.20 and $0.22.

Lannett Prices Underwritten Public Offering of Common Stock
Posted 2013-10-03 23:42NAI Editing
today announced the pricing of an underwritten public offering of 5,869,566 shares of the Company’s common stock at a price of $18.00 per share.

Lannett Names James Maher to Board of Directors
Posted 2013-06-02 23:30NAI Editing
a manufacturer of generic pharmaceuticals, today announced the appointment of James M. Maher to its Board of Directors, effective July 1, 2013.

Lannett Reports Record Fiscal 2013 Third Quarter Financial Results
Posted 2013-05-08 07:04NAI Editing
today reported continued strong momentum, with sharply improved financial results for its fiscal 2013 third quarter ended March 31, 2013, compared with the prior year period.